The treatment of choice for severe malaria is quinine. However, a gradual progression of resistance to quinine has become a concern in parts of the world. Artemisinin-related compounds are a relatively new class of drugs. This meta-analysis assesses the evidence regarding the clinical effectiveness of artemether for severe malaria. Computerized literature searches identified all randomized clinical trials of artemether in comparison with quinine. Standardized data extraction was independently performed by both authors. Results of nine trials, entered in the meta-analysis, demonstrate the absence of a significant difference between artemether and quinine in terms of mortality rate (odds ratio [OR], 0.76; 95% confidence interval [CI], 0.50 -1.14). Statistical pooling of data from trials in Southeast Asia showed a trend toward enhanced reduction of mortality (OR, 0.38; 95% CI, 0.14 -1.02). These data demonstrate the equality of artemether and quinine for severe malaria and indicate a trend toward greater effectiveness of artemether in regions where there is recognized quinine resistance.
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Malaria is one of the major infectious diseases in the world while nonrandomization may lead to substantial overestimation of the effect and thus introduce bias [18] . Therefore, today. The World Health Organization estimates that 40% of the world's population is threatened by malaria [1, 2] .
randomized controlled trials (RCTs) are needed to estimate the true clinical effectiveness of artemether for severe maThe contribution of malaria to the global burden of disease is substantial and represents a major public health concern laria. This meta-analysis is aimed at assessing the evidence from RCTs regarding the clinical effectiveness of artemether [3, 4] . The most virulent of the four Plasmodium species causing malaria in humans, Plasmodium falciparum, is pofor severe malaria. tentially life-threatening [5] and responsible for 1.5 -3.0 million deaths per year worldwide from severe malaria [6] .
Methods Quinine is the drug of choice for severe malaria [7] . However, a gradual progression of resistance to quinine has been Computerized literature searches were performed to identify recognized, especially in Southeast Asia [6, 8] . Artemisininall RCTs of artemether for severe malaria. MEDLINE, Embase, related compounds are a relatively new class of drugs for Biosis, CISCOM, and the Cochrane Library databases were the treatment of severe malaria.
searched (all from their respective inceptions to January 1998). Artemisinin, a sesquiterpene endoperoxide, is the active The search terms used were artemether, artemisinin, qinghaosu, principle of the Chinese herb qinghao (Artemisia annua) [9] .
and Artemisia annua. In addition, manufacturers of pharmaceuIn traditional Chinese medicine, extracts of qinghao have ticals containing artemether were asked to contribute published been used to treat all forms of febrile illnesses. The leaves and unpublished material. Furthermore, our own files were of cultivated A. annua are used today as raw material for searched for relevant publications. The bibliographies of the this drug class [10] . One artemisinin-related compound is studies and reviews thus retrieved were scanned for further the methyl ether derivative artemether [11] . Effectiveness studies. There were no restrictions regarding the language of of artemether in the treatment of severe malaria has been publication. suggested by a number of uncontrolled and controlled but RCTs were included if they involved patients with severe nonrandomized studies [12 -16] . Uncontrolled studies canmalaria treated with artemether and controls treated with quinot differentiate between nonspecific effects such as the natnine for comparison. Studies not involving artemether monoural course of disease and specific therapeutic effects [17], therapy were excluded. Data extraction was performed in a standardized, predefined fashion. Trial outcomes and methodological quality were independently assessed by both authors, using a standard scoring system to measure the likelihood of ware Ltd., Oxford, England). Mortality was defined as the priweighted according to sample size. Odds ratios and 95% confidence intervals were calculated with use of a random effects mary endpoint and assessed with site-specific and combined datasets. Mortality rates in the artemether and quinine arms model. Chi-squared tests were used for differences in mortality rate between the artemether and quinine groups. were used as a basis for calculating odds ratios and were / 9c63$$mr07 02-22-99 13:39:22 cida UC: CID Three trials were conducted in Southeast Asia [23, 24, 29] . Although one trial [24] showed a significantly lower mortality rate among patients treated with artemether, the overall result of these trials reveals no significant difference between artemether and quinine treatment (OR, 0.38; 95% CI, 0.14 -1.02). The survival rate was 87.5% for patients treated with artemether and 79.2% for patients treated with quinine.
Adverse effects encountered in the analyzed studies are summarized in table 2. In general, artemether was well tolerated. Patients treated with artemether experienced less frequent and generally milder adverse effects than did patients treated with quinine. for severe malaria with respect to geographic differences of to the right, in favor of quinine. study site. The increasing resistance of P. falciparum to quinine may render its use a risk factor in parts of the world [32] . Southeast Thailand, showed a significantly higher survival rate (''common'') among patients treated with artemether vs. quinine [24] . analysis is graphically depicted in figure 1. 
Results
Meta-analysis of all included studies shows no significant dif- [27] None Supraventricular tachycardia (7%)
ference between artemether and quinine in terms of mortality [28] Abdominal and injectionTinnitus, pruritus, and rate (OR, 0.76; 95% CI, 0.50 -1.14). 
